For example, in lung cancer, the blockade of either lactate production or GPR81 signaling leads to down-regulation of PD-L1 expression, thereby enhancing treatment sensitivity and reducing drug resistance [42]. This evidence concerns the gene HCAR1 and lung carcinoma.